furazolidone has been researched along with Appetite Disorders in 1 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palm, D | 1 |
| Magnus, U | 1 |
1 trial available for furazolidone and Appetite Disorders
| Article | Year |
|---|---|
[Inhibition of monoamine oxidase and diamine oxidase by furazolidone (Furoxon). Pharmacologic and biochemical studies in man].
Topics: Amine Oxidase (Copper-Containing); Blood Pressure; Clinical Trials as Topic; Feeding and Eating Diso | 1968 |